Skip to content
WeighLab
Menu
Ranked #514 · Grade C

Omzo review

Omzo is a multi-condition telehealth brand offering semaglutide, tirzepatide, and branded Ozempic access alongside women's hormone, sexual health, and skin/hair services.

Visit Omzo Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
Not disclosed
Tirzepatide
Not disclosed
Coverage
Coverage not published
Brand-name
Yes

Pricing verified August 2026

The Index scorecard

Omzo scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month45/100
Price Transparency20/100
Nationwide Access24/100
Formulation Options53/100
Clinical Oversight76/100
Contract Flexibility55/100

Where the value is

  • Broad multi-condition offering beyond weight loss (hormones, sexual health, skin, hair)
  • States semaglutide and tirzepatide are both available
  • Emphasizes licensed clinician review of every plan

The tradeoffs

  • No pricing disclosed anywhere without completing a personal-data intake quiz
  • No medical director named
  • No compounding pharmacy partner disclosed
  • No LegitScript certification or states-served information found

The bottom line

Best for: Cost-first shoppers who want not clearly assessable without pricing transparency; unsuitable to recommend confidently in a price comparison. Omzo is a multi-condition telehealth brand offering semaglutide, tirzepatide, and branded Ozempic access alongside women's hormone, sexual health, and skin/hair services.

Ranked #514 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Omzo.

The 18 programs nearest this one

Pricing, states and verification reflect Omzo's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Omzo's site. Not medical advice; see our disclosure.

← Back to the value leaderboard